Clinical medicine profile
Diphtheria
Vaccine / immunological product
- Route
- IM / SC / ORAL / ID
- Schedule
- POM
- ATC
- Not assigned
- PPB status
- registered
This profile needs source confirmation
A traceable source link is not attached to this profile. Confirm prescribing decisions against the current SmPC and Kenya STG/EML.
Safety essentials
The information most likely to change a prescribing or dispensing decision.
Contraindications
- [From component Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine] Hypersensitivity to the active substances or to any of the excipients, acute severe febrile illness.
Precautions
- [From component Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine] Temperature of 400C within 48 hours, not due to another identifiable cause, collapse or shock-like state within 48 hours, persistent crying lasting 3 hours, occurring within 48 hours, convulsions with or without fever, occurring within 3 days.
Dosing matrix
Population and organ-function guidance, shown together for faster comparison.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
Paediatric dosing is weight- and age-based; use a paediatric formulary / SmPC. Do not extrapolate adult tablets without calculation.
N/A generally.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
N/A generally.
Use, effects & interactions
Indications
- Therapeutic use is agent- and indication-specific within the class (Vaccine / immunological product).
- Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.
Adverse effects
- [From component Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine] Pain, redness or swelling at injection site, fever (more than 38C), drowsiness, irritability, unusual crying, feeding problems.
Drug interactions
Open multi-drug checker ↗- Fixed-dose/multi-ingredient product.
- Clinical details partially inherited from component monographs: Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine.
- Confirm combination SmPC for exact dosing.
Mechanism & disposition
Combination product.
Read complete mechanism
Combination product. Component mechanism (Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine): Combination product. Component mechanism (Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine): MOA-ID_37
Immune response days–weeks
Months–lifelong (schedule-dependent)
IM / SC / ORAL / ID
Pregnancy, lactation & diet
Inactivated vaccines (e.g. influenza, Tdap) often recommended; live vaccines generally avoided.
Most vaccines compatible; live vaccines usually fine for breastfeeding mother.
Brands & loaded prices
| Brand | Manufacturer | Pack | Observed price |
|---|---|---|---|
| No reviewed brand listings are linked yet. | |||
Sources & review state
Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.